- Home
- ASMB vs BWFG Comparison
ASMB vs BWFG Comparison
Compare ASMB & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASMB | BWFG |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 525.2M |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ASMB | BWFG |
|---|---|---|
| Price | $23.53 | $65.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $44.20 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 296.9K | 54.2K |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.52% |
| EPS Growth | 91.78 | ★ 261.79 |
| EPS | N/A | ★ 2.95 |
| Revenue | N/A | ★ $2,826,000.00 |
| Revenue This Year | N/A | $17.64 |
| Revenue Next Year | $638.39 | $6.21 |
| P/E Ratio | ★ N/A | $22.15 |
| Revenue Growth | N/A | ★ 43.96 |
| 52 Week Low | $21.80 | $40.45 |
| 52 Week High | $39.71 | $69.59 |
Technical Indicators
Market Signals| Indicator | ASMB | BWFG |
|---|---|---|
| Relative Strength Index (RSI) | 27.73 | 43.99 |
| Support Level | $21.80 | $63.12 |
| Resistance Level | $30.36 | $69.22 |
| Average True Range (ATR) | 1.48 | 1.27 |
| MACD | -0.64 | -0.23 |
| Stochastic Oscillator | 3.01 | 4.38 |
Price Performance
Historical ComparisonAbout ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.